Impact of Risperidone in the treatment of fecal incontinence among childre
Phase 3
- Conditions
- Functional constipation, Fecal incontinence, NDD.
- Registration Number
- IRCT20200203046352N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Functional constipation
Fecal incontinence
Age between 4 and 18
neuropsychiatric disorders in half of participants
Absence of neuropsychiatric disorders in half of participants
Exclusion Criteria
Anatomical and hormonal causes of constipation
Presence of other GI disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method